Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Relationship of cognition and psychopathology to functional impairment in schizophrenia.

Mohamed S, Rosenheck R, Swartz M, Stroup S, Lieberman JA, Keefe RS.

Am J Psychiatry. 2008 Aug;165(8):978-87. doi: 10.1176/appi.ajp.2008.07111713. Epub 2008 May 1.

PMID:
18450928
2.

Association of symptomatology and cognitive deficits to functional capacity in schizophrenia.

Perlick DA, Rosenheck RA, Kaczynski R, Bingham S, Collins J.

Schizophr Res. 2008 Feb;99(1-3):192-9. Epub 2007 Sep 12.

PMID:
17851042
3.
4.

Occupational functioning, symptoms and neurocognition in patients with psychotic disorders: investigating subgroups based on social security status.

Tandberg M, Sundet K, Andreassen OA, Melle I, Ueland T.

Soc Psychiatry Psychiatr Epidemiol. 2013 Jun;48(6):863-74. doi: 10.1007/s00127-012-0598-2. Epub 2012 Oct 13.

PMID:
23064396
5.

A structural equation modelling approach to explore the determinants of quality of life in schizophrenia.

Alessandrini M, Lançon C, Fond G, Faget-Agius C, Richieri R, Faugere M, Metairie E, Boucekine M, Llorca PM, Auquier P, Boyer L.

Schizophr Res. 2016 Mar;171(1-3):27-34. doi: 10.1016/j.schres.2016.01.012. Epub 2016 Jan 15.

PMID:
26781001
6.

Symptomatic resolution among Chinese patients with schizophrenia and associated factors.

Li CT, Su TP, Chou YH, Lee YC, Liu ME, Ku HL, Shan IK, Bai YM.

J Formos Med Assoc. 2010 May;109(5):378-88. doi: 10.1016/S0929-6646(10)60066-6.

7.

Motivational deficits and cognitive test performance in schizophrenia.

Fervaha G, Zakzanis KK, Foussias G, Graff-Guerrero A, Agid O, Remington G.

JAMA Psychiatry. 2014 Sep;71(9):1058-65. doi: 10.1001/jamapsychiatry.2014.1105.

PMID:
25075930
8.
9.

Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.

Savilla K, Kettler L, Galletly C.

Aust N Z J Psychiatry. 2008 Jun;42(6):496-504. doi: 10.1080/00048670802050512.

PMID:
18465376
10.

Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?

Brüne M, Abdel-Hamid M, Lehmkämper C, Sonntag C.

Schizophr Res. 2007 May;92(1-3):151-9. Epub 2007 Mar 7.

PMID:
17346931
11.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

12.

Towards an integrative approach to understanding quality of life in schizophrenia: the role of neurocognition, social cognition, and psychopathology.

Tas C, Brown E, Cubukcuoglu Z, Aydemir O, Danaci AE, Brüne M.

Compr Psychiatry. 2013 Apr;54(3):262-8. doi: 10.1016/j.comppsych.2012.08.001. Epub 2012 Sep 18.

PMID:
22998842
13.

[Cognition, schizophrenia and the effect of antipsychotics].

Stip E.

Encephale. 2006 May-Jun;32(3 Pt 1):341-50. Review. French.

PMID:
16840928
14.

Metacognition amidst narratives of self and illness in schizophrenia: associations with neurocognition, symptoms, insight and quality of life.

Lysaker PH, Carcione A, Dimaggio G, Johannesen JK, Nicolò G, Procacci M, Semerari A.

Acta Psychiatr Scand. 2005 Jul;112(1):64-71.

PMID:
15952947
15.

Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.

Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL.

Arch Gen Psychiatry. 2006 Dec;63(12):1325-35. Erratum in: Arch Gen Psychiatry. 2007 Mar;64(3):360.

PMID:
17146007
16.

Decision-making capacity for research participation among individuals in the CATIE schizophrenia trial.

Stroup S, Appelbaum P, Swartz M, Patel M, Davis S, Jeste D, Kim S, Keefe R, Manschreck T, McEvoy J, Lieberman J.

Schizophr Res. 2005 Dec 1;80(1):1-8. Epub 2005 Sep 22.

PMID:
16182516
17.

Patient outcomes in schizophrenia II: the impact of cognition.

Hofer A, Baumgartner S, Bodner T, Edlinger M, Hummer M, Kemmler G, Rettenbacher MA, Fleischhacker WW.

Eur Psychiatry. 2005 Aug;20(5-6):395-402.

PMID:
16171654
18.
19.

Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients.

Bellino S, Rocca P, Patria L, Marchiaro L, Rasetti R, Di Lorenzo R, Paradiso E, Bogetto F.

J Clin Psychiatry. 2004 Jul;65(7):908-14.

PMID:
15291678
20.

Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?

Tollefson GD, Andersen SW.

J Clin Psychiatry. 1999;60 Suppl 5:23-9; discussion 30. Review.

Supplemental Content

Support Center